ARADIGM CORP·4

Sep 20, 5:09 PM ET

Froehlich Juergen Kurt 4

4 · ARADIGM CORP · Filed Sep 20, 2018

Insider Transaction Report

Form 4
Period: 2018-09-19
Froehlich Juergen Kurt
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2018-09-19$1.20/sh306$36791,485 total
Footnotes (1)
  • [F1]Sold to pay the tax liability resulting from the vesting of 938 shares of restricted stock granted on March 18, 2016.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT